Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McCall

Showing results (311-320 of 501) with videos related to

Pageof 51
Sort By:
Plos One|May 26, 2017
Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell linesKen Noguchi, Annamarie C Dalton, Breege V Howley, et al.
Histopathology|April 8, 2015
Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinomaKatherine S Garman, Leandi Kruger, Samantha Thomas, et al.
PNAS Nexus|July 27, 2023
Mapping <i>Aedes aegypti</i> indoor resting behavior reveals a preference vulnerable to householder-led vector controlLuca Facchinelli, Bashir Alsharif, Jeff D Jones, et al.
The Journal of Biological Chemistry|June 7, 2018
Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1)Ken Noguchi, Toros A Dincman, Annamarie C Dalton, et al.
Cell Stem Cell|December 11, 2012
The global cell therapy industry continues to rise during the second and third quarters of 2012Chris Mason, Mark J McCall, Emily J Culme-Seymour, et al.
Communicable Diseases Intelligence Quarterly Report|June 5, 2010
An outbreak of shiga toxin-producing Escherichia coli infection associated with a school campBradley J McCall, Vicki G Slinko, Helen V Smith, et al.
Cancer Research|February 15, 1992
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapyC Kosmas, D Snook, C S Gooden, et al.
Australian Health Review : a Publication of the Australian Hospital Association|May 18, 2013
The time has come for an Australian Centre for Disease ControlBradley J McCall, Megan K Young, Scott Cameron, et al.
Nature Nanotechnology|May 8, 2013
A tiered approachMaxine J McCall, Victoria A Coleman, Jan Herrmann, et al.
European Journal of Nuclear Medicine|January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in miceM K Haseman, D A Goodwin, C F Meares, et al.
Pageof 51

Showing results (311-320 of 501) with videos related to

Sort By:
Pageof 51
Plos One|May 26, 2017
Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell linesKen Noguchi, Annamarie C Dalton, Breege V Howley, et al.
Histopathology|April 8, 2015
Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinomaKatherine S Garman, Leandi Kruger, Samantha Thomas, et al.
PNAS Nexus|July 27, 2023
Mapping <i>Aedes aegypti</i> indoor resting behavior reveals a preference vulnerable to householder-led vector controlLuca Facchinelli, Bashir Alsharif, Jeff D Jones, et al.
The Journal of Biological Chemistry|June 7, 2018
Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1)Ken Noguchi, Toros A Dincman, Annamarie C Dalton, et al.
Cell Stem Cell|December 11, 2012
The global cell therapy industry continues to rise during the second and third quarters of 2012Chris Mason, Mark J McCall, Emily J Culme-Seymour, et al.
Communicable Diseases Intelligence Quarterly Report|June 5, 2010
An outbreak of shiga toxin-producing Escherichia coli infection associated with a school campBradley J McCall, Vicki G Slinko, Helen V Smith, et al.
Cancer Research|February 15, 1992
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapyC Kosmas, D Snook, C S Gooden, et al.
Australian Health Review : a Publication of the Australian Hospital Association|May 18, 2013
The time has come for an Australian Centre for Disease ControlBradley J McCall, Megan K Young, Scott Cameron, et al.
Nature Nanotechnology|May 8, 2013
A tiered approachMaxine J McCall, Victoria A Coleman, Jan Herrmann, et al.
European Journal of Nuclear Medicine|January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in miceM K Haseman, D A Goodwin, C F Meares, et al.
Pageof 51